BNP Paribas Financial Markets’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.9M | Sell |
378,720
-541,756
| -59% | -$39.1M | 0.01% | 1014 |
|
|
2026
Q1 | $62.7M | Buy |
920,476
+91,814
| +11% | +$6.5M | 0.03% | 576 |
|
|
2025
Q4 | $62.9M | Buy |
828,662
+808,515
| +4,013% | +$58.8M | 0.03% | 579 |
|
|
2025
Q3 | $1.24M | Buy |
20,147
+7,243
| +56% | +$377K | ﹤0.01% | 2979 |
|
|
2025
Q2 | $630K | Buy |
12,904
+7,329
| +131% | +$348K | ﹤0.01% | 3180 |
|
|
2025
Q1 | $284K | Sell |
5,575
-4,717
| -46% | -$235K | ﹤0.01% | 3515 |
|
|
2024
Q4 | $465K | Sell |
10,292
-62,654
| -86% | -$2.68M | ﹤0.01% | 3355 |
|
|
2024
Q3 | $2.71M | Sell |
72,946
-54,655
| -43% | -$1.83M | ﹤0.01% | 1876 |
|
|
2024
Q2 | $3.9M | Sell |
127,601
-72,069
| -36% | -$2.33M | ﹤0.01% | 1542 |
|
|
2024
Q1 | $5.81M | Sell |
199,670
-171,910
| -46% | -$4.82M | 0.01% | 1362 |
|
|
2023
Q4 | $10.2M | Buy |
371,580
+269,292
| +263% | +$6.16M | 0.01% | 1015 |
|
|
2023
Q3 | $2.29M | Buy |
102,288
+45,553
| +80% | +$1.69M | ﹤0.01% | 1791 |
|
|
2023
Q2 | $2.31M | Sell |
56,735
-22,122
| -28% | -$1.08M | ﹤0.01% | 1668 |
|
|
2023
Q1 | $3.82M | Buy |
78,857
+11,896
| +18% | +$544K | 0.01% | 1411 |
|
|
2022
Q4 | $2.56M | Sell |
66,961
-2,961
| -4% | -$123K | ﹤0.01% | 1631 |
|
|
2022
Q3 | $3.51M | Buy |
69,922
+36,354
| +108% | +$1.78M | 0.01% | 1561 |
|
|
2022
Q2 | $1.34M | Buy |
33,568
+5,367
| +19% | +$188K | ﹤0.01% | 2009 |
|
|
2022
Q1 | $1.05M | Buy |
28,201
+13,638
| +94% | +$525K | ﹤0.01% | 2283 |
|
|
2021
Q4 | $580K | Buy |
14,563
+2,046
| +16% | +$78.3K | ﹤0.01% | 2933 |
|
|
2021
Q3 | $466K | Buy |
12,517
+9,926
| +383% | +$408K | ﹤0.01% | 2779 |
|
|
2021
Q2 | $110K | Sell |
2,591
-5,312
| -67% | -$228K | ﹤0.01% | 3017 |
|
|
2021
Q1 | $374K | Sell |
7,903
-1,359
| -15% | -$80.7K | ﹤0.01% | 2739 |
|
|
2020
Q4 | $565K | Sell |
9,262
-5,351
| -37% | -$315K | ﹤0.01% | 2398 |
|
|
2020
Q3 | $683K | Buy |
14,613
+7,925
| +118% | +$390K | ﹤0.01% | 2017 |
|
|
2020
Q2 | $339K | Sell |
6,688
-69,126
| -91% | -$3.4M | ﹤0.01% | 2255 |
|
|
2020
Q1 | $3.38M | Buy |
75,814
+67,195
| +780% | +$3.38M | 0.01% | 1191 |
|
|
2019
Q4 | $414K | Sell |
8,619
-1,751
| -17% | -$74.4K | ﹤0.01% | 2569 |
|
|
2019
Q3 | $351K | Buy |
10,370
+3,290
| +46% | +$143K | ﹤0.01% | 2401 |
|
|
2019
Q2 | $319K | Sell |
7,080
-4,982
| -41% | -$197K | ﹤0.01% | 2311 |
|
|
2019
Q1 | $454K | Buy |
12,062
+11,057
| +1,100% | +$371K | ﹤0.01% | 2158 |
|
|
2018
Q4 | $34.5K | Sell |
1,005
-1,558
| -61% | -$56K | ﹤0.01% | 2893 |
|
|
2018
Q3 | $120K | Buy |
2,563
+625
| +32% | +$25.9K | ﹤0.01% | 2646 |
|
|
2018
Q2 | $65.4K | Sell |
1,938
-6,718
| -78% | -$209K | ﹤0.01% | 2998 |
|
|
2018
Q1 | $234K | Buy |
8,656
+198
| +2% | +$5.02K | ﹤0.01% | 2706 |
|
|
2017
Q4 | $141K | Buy |
8,458
+4,467
| +112% | +$75.6K | ﹤0.01% | 3131 |
|
|
2017
Q3 | $79.9K | Sell |
3,991
-264
| -6% | -$5.17K | ﹤0.01% | 2905 |
|
|
2017
Q2 | $78K | Buy |
4,255
+3,601
| +551% | +$48.5K | ﹤0.01% | 2943 |
|
|
2017
Q1 | $6.43K | Sell |
654
-316
| -33% | -$3.83K | ﹤0.01% | 3263 |
|
|
2016
Q4 | $10.6K | Sell |
970
-1,633
| -63% | -$17.1K | ﹤0.01% | 3425 |
|
|
2016
Q3 | $36.5K | Buy |
2,603
+1,406
| +117% | +$11.4K | ﹤0.01% | 2576 |
|
|
2016
Q2 | $8.4K | Buy |
+1,197
| New | +$8.78K | ﹤0.01% | 2996 |
|
|
2016
Q1 | – | Sell |
-3,933
| Closed | -$127K | – | 2989 |
|
|
2015
Q4 | $127K | Sell |
3,933
-3,203
| -45% | -$94.3K | ﹤0.01% | 1743 |
|
|
2015
Q3 | $191K | Buy |
7,136
+4,320
| +153% | +$185K | ﹤0.01% | 1990 |
|
|
2015
Q2 | $136K | Buy |
2,816
+2,232
| +382% | +$130K | ﹤0.01% | 1916 |
|
|
2015
Q1 | $35.5K | Buy |
+584
| New | +$35.6K | ﹤0.01% | 2093 |
|
|
2014
Q4 | – | Sell |
-1,283
| Closed | -$56.5K | – | 2908 |
|
|
2014
Q3 | $56.5K | Buy |
1,283
+1,074
| +514% | +$33.6K | ﹤0.01% | 2518 |
|
|
2014
Q2 | $5.46K | Buy |
209
+105
| +101% | +$2.25K | ﹤0.01% | 2538 |
|
|
2014
Q1 | $2.03K | Sell |
104
-84
| -45% | -$2.26K | ﹤0.01% | 2655 |
|
|
2013
Q4 | $3.19K | Buy |
+188
| New | +$3.3K | ﹤0.01% | 3388 |
|
Other funds holding PTCT
RI
JT
BNP Paribas Financial Markets's PTCT Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its PTC Therapeutics (PTCT) stake by 59% in Q2 2026, selling an estimated $39.1M and leaving 378,720 shares worth $30.9M. The position accounts for 0.01% of the portfolio, ranked #1014.
BNP Paribas Financial Markets first reported a position in PTCT in Q4 2013 and has held it in 49 quarters since. The position peaked at $62.9M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- BNP Paribas Financial Markets held 378,720 shares of PTC Therapeutics worth $30.9M as of Q2 2026.
- BNP Paribas Financial Markets sold 541,756 PTC Therapeutics shares in Q2 2026, an estimated $39.1M.
- PTC Therapeutics made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1014 holding.
- BNP Paribas Financial Markets first reported a position in PTC Therapeutics in Q4 2013 and has held it in 49 quarters since.
- BNP Paribas Financial Markets's PTC Therapeutics position peaked at $62.9M in Q4 2025.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.